(Q34534991)

English

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sawko W Wassilew

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Peter Wutzler

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Brivddin Herpes Zoster Study Group

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

49-56

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antivirals for the treatment of herpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of shingles.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes zoster, chicken-pox, and cancer in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of herpes zoster and its sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of varicella zoster virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The identification of risk factors associated with persistent pain following herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(03)00065-2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34534991&oldid=1634711695"